We tested the effect of Hsp90 inhibitor treatment on cell migration in the metastatic pheochromocytoma cell line MTT and found that 17-AAG reduced serum-stimulated migration (Fig. 2A and B), with an IC50 of 144 nM. Here, HSP90AB1 is linked to pheochromocytoma.